Prenatal Substance Exposure and Neonatal Abstinence Syndrome: State Estimates from the 2016-2020 Transformed Medicaid Statistical Information System. [PDF]
West KD +4 more
europepmc +1 more source
Conflating Race and Genetics Among Newborns With Neonatal Abstinence Syndrome. [PDF]
Clark RRS, French R.
europepmc +1 more source
Neonatal Abstinence Syndrome: A Case Series. [PDF]
Malwade S, Dharmagadda A, Premkumar V.
europepmc +1 more source
ObjectivesThe magnitude, characteristics, and morbidity of term ( 6537 weeks gestation) newborns that are small-for-gestational-age (SGA) in the U.S. are underexplored.
core
Trends of prenatal opioid utilization and neonatal abstinence syndrome in Manitoba, Canada: A 26-year population-based cohort study. [PDF]
Abulannaz O +6 more
europepmc +1 more source
Hypothermia as a Presenting Sign of Venlafaxine-Induced Neonatal Abstinence Syndrome in 2 Neonates. [PDF]
Oswald M, El-Chaar G, Canter M.
europepmc +1 more source
Integrated Review of the Assessment of Newborns With Neonatal Abstinence Syndrome. [PDF]
Casavant SG +5 more
europepmc +1 more source
Correction: Disparity in neonatal abstinence syndrome by race/ethnicity, socioeconomic status, and geography, in neonates ≥ 35 weeks gestational age. [PDF]
Dookeran KA +5 more
europepmc +1 more source
Understanding the effects of opioids vs non-opioids in the treatment of neonatal abstinence syndrome, an in vitro model. [PDF]
Sithisarn T +4 more
europepmc +1 more source

